SiNtx Technologies Aktie
WKN DE: A2PPL3 / ISIN: US8293923079
|
19.03.2025 14:10:39
|
SINTX: Peer-reviewed Study Shows Biomechanical Advantages Of Silicon Nitride In ACDF Procedures
(RTTNews) - SINTX Technologies, Inc. (SINT) announced the publication of a new peer-reviewed study demonstrating the biomechanical advantages of silicon nitride in anterior cervical discectomy and fusion procedures. The study was conducted by researchers at SRM Institute of Science and Technology in collaboration with SINTX Technologies. The results highlight silicon nitrides superior biomechanical performance, particularly in reducing implant subsidence, improving load distribution, and enhancing spinal stability.
The company said it continues to engage with strategic partners to drive adoption of silicon nitride-based medical devices, including cervical interbody fusion cages and other orthopedic applications.
Shares of SINTX Technologies are up 7% in pre-market trade on Wednesday.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu SiNtx Technologies Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |